calendar
2,452 catalysts · 3,921 phase readout · 2,127 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
2,452 catalysts · 3,921 phase readout · 2,127 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 109 grant
Items: 7.01, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 2.02, 7.01, 8.01, 9.01
Items: 3.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.07
Items: 7.01, 9.01
Items: 5.02
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 3.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.03, 5.07, 9.01
Items: 2.02, 9.01
Items: 5.02
Items: 4.02
Items: 5.02
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 3.02, 8.01, 9.01
Items: 8.01, 9.01
Items: 1.02, 9.01
Items: 1.01, 2.03, 3.01, 3.03, 9.01
Items: 2.05, 7.01, 9.01
Anticipated earnings call for IONIS PHARMACEUTICALS INC ($IONS).
Anticipated earnings call for Avantor, Inc. ($AVTR).
Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease
Anticipated earnings call for MERIT MEDICAL SYSTEMS INC ($MMSI).
Anticipated earnings call for Merck & Co., Inc. ($MRK).
Anticipated earnings call for CARDINAL HEALTH INC ($CAH).
Anticipated earnings call for DEXCOM INC ($DXCM).
Anticipated earnings call for ELI LILLY & Co ($LLY).
Anticipated earnings call for STRYKER CORP ($SYK).
Anticipated earnings call for BRISTOL MYERS SQUIBB CO ($BMY).
Anticipated earnings call for AMGEN INC ($AMGN).
Anticipated earnings call for BIOMARIN PHARMACEUTICAL INC ($BMRN).
Anticipated earnings call for BAXTER INTERNATIONAL INC ($BAX).
Anticipated earnings call for CORCEPT THERAPEUTICS INC ($CORT).
Anticipated earnings call for Travere Therapeutics, Inc. ($TVTX).
Anticipated earnings call for ARVINAS, INC. ($ARVN).
Anticipated earnings call for ALNYLAM PHARMACEUTICALS, INC. ($ALNY).
Anticipated earnings call for Summit Therapeutics Inc. ($SMMT).
Anticipated earnings call for ILLUMINA, INC. ($ILMN).
Anticipated earnings call for TENET HEALTHCARE CORP ($THC).